These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 2104076

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY, Stambuk D.
    Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced oral bioavailability of meptazinol in cirrhosis.
    Birnie GG, Thompson GG, Murray T, Watkinson G, Brodie MJ.
    Gut; 1987 Mar; 28(3):248-54. PubMed ID: 3570028
    [Abstract] [Full Text] [Related]

  • 10. Oral and intravenous pharmacokinetics of ranitidine in patients with liver cirrhosis.
    Okolicsanyi L, Venuti M, Strazzabosco M, Orlando R, Nassuato G, Iemmolo RM, Lirussi F, Muraca M, Pastorino AM, Castelli G.
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):329-32. PubMed ID: 6086536
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects.
    Pentikäinen PJ, Välisalmi L, Himberg JJ, Crevoisier C.
    J Clin Pharmacol; 1989 Mar; 29(3):272-7. PubMed ID: 2723115
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of famotidine in children with gastroduodenal ulcers.
    Nagita A, Manago M, Aoki S, Mino M, Suzuki K, Ashida K.
    Ther Drug Monit; 1994 Oct; 16(5):444-9. PubMed ID: 7846741
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis.
    Okolicsányi L, Venuti M, Strazzabosco M, Iemmolo RM, Nassuato G, Orlando R, Lirussi F.
    Acta Physiol Hung; 1984 Oct; 64(3-4):393-400. PubMed ID: 6099684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.